Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 3,7-dimethyl-1-propargylxanthine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 3,7-dimethyl-1-propargylxanthine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(3,7-dimethyl-1-propargylxanthine)
Trials
(3,7-dimethyl-1-propargylxanthine)
Recent Studies (post-2010) (3,7-dimethyl-1-propargylxanthine)
9,156187552202123

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, BF; Raschke, P1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 3,7-dimethyl-1-propargylxanthine

ArticleYear
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
    Cardiovascular research, 1995, Volume: 29, Issue:4

    Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines

1995